1) 藤田直. 活性酸素 、過 酸化脂質 、フ リーラジカルの生成と消去機構並びにそれらの生物学的作用. 薬学雑誌 2002; 122: 203- 218.
2) 吉川敏一、内藤裕二、近藤元治. フリーラジカルとは. 『 フリーラジカルと和漢薬（ 奥田拓男、 吉川敏一 編 ）』 . 国際医書出版 1990; pp 11- 16 .
3) 内田浩二. 活性酸素による脂質過酸化と蛋白質変性： 酸化ストレス産物および酸化ストレス源としての反応性アルデヒド . Jpn J Electroph 2000; 44: 265- 269.
4) 二木鋭雄. 生体の酸化的傷害とそれに対する防御システム. 『 抗酸化物質— フリーラジカルと生体防御―（ 二木鋭雄、島崎弘幸、美濃真 編 ）』. 学会出版センター 1994; pp 3- 15 .
5) 江口裕伸、藤原範子、大河原知水、鈴木敬一郎、谷口直之. 酸化ストレスと健康. 生体試料分析 2009 ; 32: 247 - 256 .
6) 佐々木 徹. 自然老化動物を用いた酸化ストレスの解析と抗老化研究. 薬学雑誌 2010 ; 130: 29 - 42
7) Steinberg D. Low density Lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272 : 20963 - 20966
8) Niki E. Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. J Clin Biochem Nutr 2011 ; 48: 3- 7.
9) González J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: New insights. World Journal of Cardiology 2014; 6 : 353- 366.
10) 宮下和夫. 脂肪酸、リン脂質の水溶液中での劣化. 『 脂質栄養と脂質過酸化― 生体内脂質過酸化は傷害か防御か―（ 奥山治美、菊川清見 編 ）』. 学会出版センター 1998; pp 85- 94.
11) Kaizu H, Sasaki M, Nakajima H, Suzuki Y. Effect of antioxidative lactic acid bacteria on rats fed a diet deficient in vitamin E. J Dairy Sci 1993; 76 : 2493- 2499 .
12) Ahothpa M, Saxelin M, Korpela R. Antioxidative properties of Lactobacillus GG. Nutr Today Suppl 1977 ; 31 : 51S- 52S.
13) Lin MY, Yen CL. Antioxidative ability of lactic acid bacteria. J Agric Food Chem 1999 ; 47: 1460 - 1466 .
14) Lin MY, Yen CL. Reactive oxygen species and lipid peroxidation product- scavenging ability of yogurt organisms. J Dairy Sci 1999; 82: 1629- 1634.
15) Lin MY, Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci 2000; 45: 1617 - 1622.
16) Stecchini ML, Torre MD, Munari M. Deter mination of peroxy radic al - scavenging of lactic acid bacteria. Int J Food Microbiol 2001; 64 : 183 - 188.
17) 吉野芳夫、折茂英生、平井幸彦、久安早苗、佐藤久美子. 鉄. 『 ミネラル・微量元素の栄養 学（ 鈴木継美 、和 田攻 編 ）』. 第一出版 1994: pp351- 376 .
18) Younes M, Trepkau HD, Siegers CP. Enhancement by dietary iron of lipid peroxidation in mouse colon. Res Commun Chem Pathol Pharmacol 1990; 70: 349 - 354.
19) Porres JM, Sathl CH, Chang WH, Fu Y, Roneker KR, Pond WG, Lei XG. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. Proc Soc Exp Biol Med 1999; 221 : 80 - 86.
20) Ito M, Sawada H, Ohishi K, Yoshida Y, Yokoi W, Watanabe T, Yokokura T. Suppressive effects of bifidobacteria on lipid peroxidation in the colonic mucosa of iron- overloaded mice. J Dairy Sci 2001; 84: 1583 - 1589.
21) Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994; 56: 379- 382 .
22) Nelson RL. Dietary iron and colorectal cancer risk. Free Radic Biol Med 1992; 12: 161 - 168 .
23) Siegers CP, Bumann D, Baretton G, Younes M. Dietary iron enhances the tumor rate in dimetylhydrazine- induced colon carcinogenesis in mice. Cancer Lett 1988 ; 41: 251 - 156 .
24) Wurzelmann JI., Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev 1996 ; 5: 503 - 507.
25) Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990 ; 8 : 191 - 200.
26) Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992; 13: 169- 181.
27) Porres JM, Stahl CH, Cheng WH, Fu Y, Roneker KR, Pond WG, Lei XG. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. Proc Soc Exp Biol Med 1999; 221 : 80 - 86
28) Miyazaki K, Matsuzaki T. Health properties of milk fermented with Lactobacillus casei strain Shirota ( Lc S). In: Farnworth ER ( ed). Handbook of fermented functional foods. CRC Press. 2008 ; pp165 - 208 .
29) American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr 1977; 107: 1340 - 1348.
30) Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Natl Cancer Inst 1997 ; 89: 1006 - 1014.
31) Kot E, Furmanov S, Bezkorovainy A. Accumulation of iron in lactic acid bacteria and bifidobacteria. J Food Sci 1995; 60: 547 - 550.
32) Hallberg L, Brune M, Rossander L. Iron absorption in man: ascorbic acid and dose- dependent inhibition by phytate. Am J Clin Nutr 1989 ; 49: 140- 144 .
33) Pallauf J, Pippig S, Most E, Rimbach G. Supplemental sodium phytate and microbial phytate influence iron availability in growing rats. J Trace Elem Med Biol 1999; 13: 134 - 140 .
34) Sawa T, Akaike T, Kida K, Fukushima Y, Takagi K, Maeda H. Lipid peroxyl radicals from oxydized oils and heme- iron: Implication of a high- fat diet in colon carcinogenesis. Cancer Epidemiol Biomark Prev 1998; 7 : 1007- 1012.
35) Mc Kenzie SJ, Baker MS, Buffinton GD, Doe WF. Evidence of oxidant- injury to epithelial cells during inflammatory bowel disease. J Clin Inves. 1996; 98 : 136 - 141.
36) Pearson DC, Jourd' heuil D, Meddings JB. The anti- oxidant properties of 5- aminosalicylic acid. Free Radic Biol Med 1996; 21: 367 - 373 .
37) Araki Y, Sugihara H, Hattori T. The free radical scavengers edaravone and tempol suppress experimental dextr an sulfate sodium - induced colitis in mice. Int J Mo. Med 2006; 17 : 331- 334 .
38) Simmonds NJ, Allen RE, Stevens TR, Van Someren RNM, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gasteroenterology 1992; 103: 186- 196.
39) Sedghi S, Fields JZ, Klamut M, Urban G, Durkin M, Winship D, Fretland D, Olyaee M, Keshavarzian A. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut 1993; 34: 1191 - 1197 .
40) Okayasu, I ., H atakey ama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology, 98, 694- 702 ( 1990)
41) Gaudio E, Taddei G, Vetuschi A, Sferra R, Frieri G, Ricciardi G, Caprilli R. Dextran sulfate sodium ( DSS) colitis in rats – clinical, structural, and ultrastractural aspects. Dig Dis Sci 1999; 44 : 1458 - 1475.
42) Oz HS, Chen TS, Mc Clain CJ, de Villiers WJS. Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem 2005; 16: 297 - 304.
43) Jiao Q, Liu Q. Simple spectrophotometric method for the estimation of algal polysaccharide concentrations. J Agric Food Chem 1999; 47: 996- 998.
44) Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69 : 238 - 249.
45) Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assesment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344 - 1350 .
46) Han W, Mercenier A, Ait- Belgnaoui A, Pavan S, Lamine F, van Swan II, Kleerebezem M, Salvador- Cartier C, Hisberguers M, Bueno L, Theodorou V, Fioramonti J. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 2006 ; 12: 1044 - 1052 .
47) Carroll IM, Andrus JM, Bruno- Bárcena JM, Klaenhammer TR, Hassan HM, Threadgill DS. Anti- inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10 - deficient mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2007; 293: G 729 - G 738.
48) Iwai A, Iwashita E. Changes in colonic inflammation induced by dextran sulfate sodium ( DSS) during short - and long- term administration of Rebamipide. Dig Dis Sci 1998 ; 43: 143S - 147S.
49) Gonzalez R, de Sanchez MF, Galvez J, Rodriguez- Cabezas ME, Duarte J, Zarzuelo A. Dietary vitamin E supplementation protects the rat large intestine from experimental inflammation. Int J Vitam Nutr Res 2001; 71: 243- 250.
50) Adhdassi E, Carrier J, Cullen J, Tischler M, Allard JP. Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis. Dig Dis Sci 2001; 46: 1088 - 1094 .
51) Fruebis J, Silvestre M, Shelton D, Napoli C Palinski W. Inhibition of VCAM- 1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J Lipid Res 1999; 40: 1958 - 1966.
52) Miyazaki K, Makino K, Iw adate E, Deguchi Y, Ishikawa F. Anthocyanins from purple sweet potato lpomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule- 1 in apolipoprotein E- deficient mice. J Agricul Food Chem 2008 ; 56: 11485 - 11492.
53) Ling WH, Wang LL, Ma J. Supplementation of the black rice outer layer fraction to rabbits decreases ather osclerotic plaque formation and increases antioxidant status. J Nutri 2002; 132 : 20- 26
54) Vinson JA, Teufel K, Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2001 ; 156: 67 - 72.
55) Xu R, Yokoyama WH, Irving D, Rein D, Walzem RL, German JB. Effect of dietary catechin and vitamin E on aortic fatty streak accumulation in hypercholesterolemic hamsters. Atherosclerosis 1998; 137: 29 - 36 .
56) Aoki T, Abe T, Yamada E, Matsuto T, Okada M. Increased LDL susceptibility to oxidation accelerates future carotid art ery atherosclerosis. Lipids Health Dis 2012; 11: 4.
57) Hendrickson A, Mc Kinstry LA, Lewis JK, Lum J, Louie A, Schellenberg GD, Hatsukami TS, Chait A, Jarvik GP. Ex vivo measures of LDL oxidative susceptibility predict carotid artery disease. Atherosclerosis 2005 ; 179: 147 - 153.
58) Regnström J, Nilsson J, Tornvall P, Landou C, H amsten A. Susceptibility to low- density lipoprotein and coronary atherosclerosis in man. Lancet 1992 , 339 : 1183 - 1186
59) Spady DK, Dietschy JM. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Pro c Natl Acad Sci U S A 1985; 82: 4526 - 4530.
60) Srivastava R A, He S. Anti- hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster. Mol Cell Biochem 2010; 345 : 197- 206.
61) Asami Y, Yamagishi I, Akiyoshi K, Tomoike H, Tsuchida K, Higuchi S. Inhibitory effect of TS- 962 on the formation of early atherosclerotic lesions in high fat- fed hyperlipidemic hamsters. Atherosclerosis 1999; 146: 237- 242.
62) Auger C, Caporiccio B, Landrault N, Teissedre PL, Laurent C, Cros G, Besancon P, Rouanet JM. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters ( Mesocricetus auratus). J Nutr 2002; 132 : 1207 - 1213.
63) Nistor AN, Bulla A, Filip DA, Radu A. The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 1987 ; 68: 159- 173.
64) Kano M, Takayanagi T, Harada K, Makino K, Ishikawa F, 2005. Antioxidative actibity of anthocyanins from purple sweet potato, Ipomoera batatas cultivar Ayamurasaki. Biosci Biotechnol Biochem 2005; 69: 979- 988.
65) Hirano R, Kondo K, Iwamoto T, Igarashi O, Itakura H. Effects of antioxidants on the oxidative susceptibility of low- density lipoprotein. J Nutri Sci Vitaminol 1997; 43: 435- 444.
66) Asami Y, Yamagishi I, Akiyoshi K, Tomoike H, Tsuchida K, Higuchi S. Inhibitory effect of TS- 962 on the formation of early atherosclerotic lesions in high fat- fed hyperlipidemic hamsters. Atherosclerosis 1999; 146: 237- 242.
67) Keidar S, Kaplan M, Shapira C, Brook JG, Aviram M. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II. Atherosclerosis 1994; 107: 71- 84.
68) Lavy A, Brook GJ, Dankner G, Ben- Amotz A. Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991 , 40: 794 - 799.
69) Scheffler E, Huber L, Fruhbis J, Schulz I, Ziegler R, Dresel HA. Alteration of plasma low density lipoprotein from smokers. Atherosclerosis 1990 ; 82: 261 - 265.
70) Yoshida H, Ishikawa T, Nakamura H. Vitamin E/ lipid peroxide ratio and susceptibility of LDL to oxidative modification in non - insulin- dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1997 ; 17 : 1438- 1446.
71) Terahara M, Kurama S, Takemoto N. Prevention by lactic acid bacteria of the oxidation of human LDL. Biosci Biotechnol Biochem 2001; 65: 1864- 1868.
72) Mater DDG, Bretigny L, Firmesse O, Flor es MJ, Mogenet A, Bresson JL, Corthier G. Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus survive gastroin testinal transit of healthy volunteers consuming yogurt. FEMS Microbiol Lett 2005; 250 : 185- 187.
73) Marteau P, Minekus M, Havenaar R, Huis in’t Veld, JHJ. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 1997; 80: 1031 - 1037.
74) Ellman GL. Tissue sulfhydryl groups. Archives Biochem Biophys 1959; 82: 70- 77 .
75) 東胤昭. システインの貯蔵型（ 輸送型）としての肝臓グルタチオン. 栄養と食糧 1980 ; 33( 4): 203- 218 .
76) Mc Menamin ME, Himmelfarb J, Nolin TD. Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with f luorescence detection. J chromaotgr B 2009; 877: 3274- 3281.
77) Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione. Eur J Clin Pharmacol 1992; 43: 667 - 669.
78) Lauver DA, Kaissarian NM, Lucchesi BR. Oral pretreatment with liposomal glutathione attenuates reperfusion injury in rabbit isolated hearts. J Cardiov asc Pharmacol 2013; 61 : 233 - 239.
79) Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde- modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998; 98: 1487- 1494.
80) Kametsu Y, Kitagawa Y, Sekiyama S, Takagi S. Increase in plasma malondialdehyde- modified low- density lipoprotein in patients with atherothrombotic cerebral infraction. The Tokai J Exp Clin Med 2005; 30: 171- 176 .
81) Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, Kanno T, Saito Y. Increased circulating malondialdehyde- modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 2002 ; 22: 662- 666.
82) Matsuo Y, Tubo T, Okumoto Y, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Hirata K, Imanishi T, Akagi H, Akasaka T. Circulating malondialde- modified low- density lipoprotein levels are associated with the presence of thin- cap f ibroatheromas determined by optical coherence tomography in cor onary artery disease. E uro Heart J Cardiovasc Imaging 2013; 14: 43 - 50.
83) Tajika K, Okamatsu K, Takano M, Inami S, Yamamoto M, Murakami D, Kobayashi N, Ohba T, H ata N, Seino Y, Mizuno K. Malondialdehyde- modified low- density lipoprotein is a useful marker to identify patients with vulnerable plaque. Circulation J 2012 ; 76: 2211- 2217 .
84) Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K, Yatoh S, Takahashi A, Yahagi N, Yagyu H, Sone H, Shimano H. Circulating malondialdehyde - modified LDL- related variables and coronary artery stenosis in asymptomatic patients with type 2 diabetes. J Diabetes Res 2015: article ID 507245 .
85) Ono M, Takabe N, Oda T, Nakag awa R, M atsui M, Sasai T, Nag asawa K, Honma H, Kajiwara T, Taneichi H, Takahashi Y, Takahashi K, Satoh J. Association of coronary artery calcification with MDA - LDL/ LDL- C and urinary 8 - isoprostane in Japanese patients with type 2 diabetes. Intern Med 2014; 53 : 391 - 396.
86) Kotani K, Maekawa M, Kanno T, Kondo A, Toda N, Manabe M. Distribution of immunoreactive malondialdehyde- modified low-density lipoprotein in human serum. Biochim Biophys Acta 1994; 1215: 121- 125 .
87) Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi H, Egusa G, Hiro T, Hirobe K, Iida M, Kihara S, Kinoshita M, Maruyama C, Ohta T, Okamura T, Yamashita S, Yokode M, Yokote K. Diagnostic criteria of dyslipidemia. Executive summary of the Japan Atherosclerosis Society ( JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan – 2012 version. J Atheroscler Thromb 2012; 20: 655 - 660 .
88) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001. Executive summary of the Third Report of the National Cholesterol Education Pr ogram ( NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult treatment panel III). J Am Med Assoc 2001; 285: 2486 - 2497.
89) Fujiyoshi A, Ohkubo T, Miura K, Murakami Y, Nagasawa S, Okamura T, Ueshima H, for the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan ( EPOCH - JAPAN) Research Group. Blood pressure categories and long- term risk of cardiovascular disease according to age group in Japanese men and women. Hypertens Res 2012; 35: 947- 953.
90) Miura K, Nakagawa H, Ohashi Y, Harada A, Taguri M, Kushiro T, Takahashi A, Nishinaga M, Soejima H, Ueshima H for the Japan Arteriosclerosis Longitudinal Study ( JALS) group. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: A meta- analysis of 16 cohort studies. Circulation 2009; 119 : 1892 - 1898.
91) Beltrán- Barrientos LM, Hernández- Mendoza A, Torres- Llanez MJ, González- Córdova AF, Vallejo- Córdova B. Invited review: Fermented milk as antihypertensive functional food. J Dairy Sci 2016; 99 : 4099- 4110.
92) Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidativ e stress in renovascular hypertension. N Engl J Med 2002 ; 346: 1954 - 1962.
93) Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006 ; 71: 247 - 258 .
94) Uriot O, Denis S, Junjua M, Roussel Y, Dary- Mourot A, Blanquet- Diot S. Streptococcus thermophilus: From yogurt starter to a new promising probiotic candidate? J Funct Foods 2017 ; 37: 74 - 89 .
論文の公開元へ
